Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial.

Abstract

In recent-onset branch retinal vein occlusion, no significant difference was found in the final visual acuity between the patients treated by dalteparin or aspirin. A further study with larger sample size is recommended.